期刊文献+

β-雌二醇及其纳米粒对肝星状细胞TGF-β1和CTGF的影响

The effect of TGF-β1 and CTGF treated with β-estradiol nanoparticle and β-estradiol on activated rat hepatic stellate cells
暂未订购
导出
摘要 目的本研究首先观察纳米化后的β-雌二醇纳米粒是否和普通β-雌二醇一样对HSC增殖仍具有抑制作用;再比较β-雌二醇和β-雌二醇纳米粒对TGF-β1和其下游信号CTGF mRNA和蛋白表达的影响;进一步探讨β-雌二醇和β-雌二醇纳米粒抗肝纤维化的机制。方法①用不同浓度的β-雌二醇、β-雌二醇纳米粒干预HSCs,噻唑蓝(MTT)法检测不同时间点β-雌二醇、β-雌二醇纳米粒对HSCs增殖的影响。②用逆转录-聚合酶链式反应(RT-PCR)方法检测分析其对HSCs的TGF-β1、CTGF的mRNA表达的影响。③用免疫细胞化学方法分析其对HSCs的TGF-β1、CTGF蛋白的表达的影响。结果MTT法发现β-雌二醇、β雌二醇纳米粒都能抑制HSCs的增殖,下调HSCs TGF-β1 mRNA、CTGF mRNA的表达,减少HSCs TGF-β1、CTGF蛋白表达量,且β-雌二醇纳米粒作用更强。结论β-雌二醇纳米粒和β-雌二醇一样具有抑制HSC增殖的作用,其抗肝纤维化的机制可能是通过抑制TGF-β1及其下游信号CTGF的mRNA和蛋白表达有关。 Objective To observe whether β-estradiol nanoparticle has the same suppressive effects on HSCs proliferation as β-estradiol, and then compare their effect on the expression of mRNA and protein of TGF-β1and its downstream signaling CTGF. The anti-fibrotic mechanism of β-estradiol and β-estradiol nanoparticles is further investigated. Methods Hepatic stellate ceils were treated with different concentration of β-estradiol and β-estradiol nanoparticle, then their effects on the proliferation of HSCs were detected by MTT. Hepatic stellate ceils were treated with 10^-8mol/L of β-estoadiol or β-estoadiol nanoparticle for 48 h, detected by RT-PCR, then expression of TGF-β1 and CTGF mRNA and protein in hepatic stellate ceils were detected by RT-PCR or Immunocytochemistry. Results The suppressive effect of β-estradiol and β-estradiol nanoparticle on the proliferation of activated HSCs were confirmed . We found that β-estradiol and β-estradiol nanoparticle down-regulate the expression of TGF-β1 and CTGF mRNA and protein. There was significant of difference between the effect of β-estradiol and β-estradiol nanoparticle. β-estradiol nanoparticle had better effect than β-estradiol. Conclusion Both β-estradiol nanoparticle and β-estradiol have anti-fibrosis function. The antifibrosis mechanisms of β-estradiol nanoparticle and β-estradiol may be result from the following factors: inhibiting the proliferation of HSCs, suppressing the expression of pro-fibrogenic cytokine TGF-β1 and it's downstream signaling CTGF which play an essential role in the process of hepatic fibrosis.
出处 《胃肠病学和肝病学杂志》 CAS 2007年第6期561-565,共5页 Chinese Journal of Gastroenterology and Hepatology
基金 湖南省自然科学基金(03GGY3060)
关键词 雌二醇 雌二醇纳米粒 肝星状细胞 转化生长因子Β1 结缔组织生长因子 Estradiol Estradiol nanoparticle Hepatic stellate cells TGF-β1 CTGF
  • 相关文献

参考文献10

  • 1Lu G, Shimizu I, Cui X, et al. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats[ J]. Life Sci, 2004, 74 ( 7 ) : 897-907.
  • 2Itagaki T, Shimizu I, Cheng X, et al. Opposing effects of oestradiol and progesterone on intraeellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells[J]. Gut, 2005, 54(12) : 1782-1789.
  • 3Vauthier C, Dubernet C, Fattal E, et al. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications[ J]. Adv Drug DelivRev, 2003, 55 (4): 519-548.
  • 4谢建萍,谭德明,肖平,潘一峰,周建亮.β-雌二醇聚氰基丙烯酸正丁酯纳米粒制备工艺的研究[J].中国医学工程,2006,14(5):452-455. 被引量:7
  • 5谢建萍,周建亮,刘菲,潘一峰,全俊,谭德明.雌二醇聚氰基丙烯酸正丁酯纳米粒肝脏靶向性研究[J].中国医学工程,2007,15(4):312-315. 被引量:5
  • 6Yoshikawa T, Tsutsumi Y, Nakagawa S. Development of nanomedicine using intracellular DDS [ j ]. Nippon Rinsho, 2006, 64 ( 2 ) : 247-252.
  • 7Shimizu I, Mizobuchi Y, Yasuda M, et al. Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro[ J]. Gut, 1999, 44(1) : 127-136.
  • 8刘菲,谢建萍,刘双虎,冯德云.肝纤维化大鼠性激素的变化及己烯雌酚对大鼠肝纤维化影响的实验研究[J].中国现代医学杂志,2003,13(5):36-39. 被引量:7
  • 9Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGF-beta in hepatic fibrosis[ J]. Front Biosci, 2002, 7 :d 793-807.
  • 10Kobayashi H, Hayashi N, Hayashi K, et al. Connective tissue growth factor and progressive fibrosis in biliary atresia[ J]. Pediatr Surg Int, 2005, 21(1) : 12-16.

二级参考文献16

  • 1张阳德,李浩.纳米载体肝靶向纳米药物研究进展[J].中国医学工程,2003,11(6):75-77. 被引量:10
  • 2张顺财,王吉耀,刘厚钰,朱无难.门体分流在肝硬化患者性激素改变中的作用[J].上海医科大学学报,1996,23(1):22-24. 被引量:5
  • 3谢建萍,谭德明,肖平,潘一峰,周建亮.β-雌二醇聚氰基丙烯酸正丁酯纳米粒制备工艺的研究[J].中国医学工程,2006,14(5):452-455. 被引量:7
  • 4[2]ILLUM L,DAVIS SS,MULLER RH,et al.The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908[J].Life Sci,1987,40(4):367-374.
  • 5[3]VAUTHIER C,DUBERNET C,FATTAL E,et al.Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications[J].Adv Drug Deliv Rev,2003,55(4):519-548.
  • 6[4]SIMEONOVA M,CHORBADJIEV K.ANTCHEVA M.Study of the effect of polybutylcyanoacrylate nanoparticles and their metabolites on the primary immune response in mice to sheep red blood cells[J].Biomaterials,1998,19(23):2187-2193.
  • 7[5]MIYAZAKI S,TAKAHASHI A,KUBO W,et al.Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs:in vitro release and in vivo skin penetration[J].J Pharm Pharm Sci,2003,6(2):238-245.
  • 8[6]PUGLISI G,FRESTA M,GIAMMONA G,et al.Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation[J].International Journal of Pharmaceutics,1995,125(2):283-287.
  • 9[7]PERACCHIA MT,VAUTHIER C,DESMAELE D,et al.Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer[J].Pharm Res,1998,15(4):550-556.
  • 10[8]VANDELLI MA,FRESTA M,PUGLISI G,et al.An interpretative analysis of the effect of the surfactants used for the preparation of polyalkylcyanoacrylate nanoparticles on the release process[J].J Microencapsul,1994,11(5):531-538.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部